Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IPI≥2”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Large-scale testing (Phase 3)UnknownNCT00499018
What this trial is testing

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaIPI≥2
Fondazione Italiana Linfomi - ETS 399
Large-scale testing (Phase 3)Ended earlyNCT03839355
What this trial is testing

Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Mayo Clinic 34
Not applicableStudy completedNCT05731349
What this trial is testing

Impact of Early Sepsis Care Guided by the National Early Warning Score 2 in the Emergency Department

Who this might be right for
SepsisSeptic Shock
The University of Hong Kong 200
Testing effectiveness (Phase 2)Study completedNCT02089685
What this trial is testing

Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)

Who this might be right for
Renal Cell CarcinomaMelanoma
Merck Sharp & Dohme LLC 295
Not applicableStudy completedNCT05284500
What this trial is testing

Predictive Pre and Peroperative Factors for MODS-2 in Pediatric Cardiac Surgery

Who this might be right for
Congenital Heart Disease in ChildrenCardiac Surgical ProceduresOutcome Assessment+1 more
Brugmann University Hospital 152
Not applicableStudy completedNCT07188727
What this trial is testing

Comparative Outcomes of Ulcerative Colitis Patients With Mayo Endoscopic Score 1 and Histologic Activity Versus Mayo Endoscopic Score 2

Who this might be right for
Ulcerative Colitis (UC)
IRCCS San Raffaele 159
Testing effectiveness (Phase 2)Study completedNCT00144807
What this trial is testing

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell Lymphoma
Lymphoma Study Association 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT04413123
What this trial is testing

Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC

Who this might be right for
Papillary Renal Cell CarcinomaUnclassified Renal Cell CarcinomaTranslocation Renal Cell Carcinoma+5 more
Bradley A. McGregor, MD 60
Testing effectiveness (Phase 2)Study completedNCT00498043
What this trial is testing

Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma

Who this might be right for
Lymphoma, B-CellLymphoma, Large-Cell, Diffuse
Hospices Civils de Lyon 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT03463057
What this trial is testing

The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL

Who this might be right for
NHLDLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland 109
Testing effectiveness (Phase 2)Study completedNCT00169143
What this trial is testing

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

Who this might be right for
Untreated CD20-positive Large B-cell Lymphoma
Lymphoma Study Association 60
Not applicableUnknownNCT01860508
What this trial is testing

PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers

Who this might be right for
Non-small Cell Lung Cancer
Fudan University 94
Not applicableUnknownNCT02341066
What this trial is testing

Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis (EDRA Study)

Who this might be right for
Rheumatoid ArthritisCoronary Heart Disease
Azienda Ospedaliero Universitaria di Sassari 3,000
Early research (Phase 1)Study completedNCT03283202
What this trial is testing

Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors

Who this might be right for
Diffuse B-Cell Lymphoma
Celgene 35
Testing effectiveness (Phase 2)Study completedNCT03129828
What this trial is testing

Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2

Who this might be right for
Diffuse Large B Cell Lymphoma
Prof. Dr. Clemens Schmitt 38
Not applicableUnknownNCT06310915
What this trial is testing

Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IV
Guangzhou Institute of Respiratory Disease 30
Testing effectiveness (Phase 2)Study completedNCT01502982
What this trial is testing

Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Nordic Lymphoma Group 160
Not applicableNot Yet RecruitingNCT07732517
What this trial is testing

Simplified Acute Physiology Score 2 and Pressure Ulcer Prediction in ICU.

Who this might be right for
Pressure Ulcers
University Hospital, Bordeaux 500
Testing effectiveness (Phase 2)WithdrawnNCT00969917
What this trial is testing

Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Infinity Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT07252830
What this trial is testing

Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid and Coronary Explorations, Compared to Simple Risk Calculation Using the European "SCORE 2" Algorithm. (IDEA-CVR)

Who this might be right for
Myocardial InfarctionAtheromaCholesterol+1 more
Elsan 1,000
Next Page